Gene · 4593
Papers3,141
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
701 to 720 of 3,141
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Alignment of Skeletal Muscle Cells Facilitates Acetylcholine Receptor Clustering and Neuromuscular Junction Formation with Co-Cultured Human iPSC-Derived Motor Neurons. | Cells | 2022 | 36497020 | PubTator, text mining | PubMed |
| Polymorphisms in drug metabolism genes predict the risk of refractory myasthenia gravis. | Ann Transl Med | 2022 | 36467365 | PubTator, text mining | PubMed |
| Wealth Without Limits: in Defense of Billionaires. | Ethical Theory Moral Pract | 2022 | 36466110 | PubTator, text mining | PubMed |
| Myasthenia Gravis in the Setting of Immune Checkpoint Inhibitor Therapy: Practical Considerations and Opinion-Based Approach to Acute Management. | Cureus | 2022 | 36439604 | PubTator, text mining | PubMed |
New insights in pediatrics in 2021: choices in allergy and immunology, critical care, endocrinology, gastroenterology, genetics, haematology, infectious diseases, neonatology, neurology, nutrition, palliative care, respiratory tract illnesses and telemedicine. | Ital J Pediatr | 2022 | 36435791 | PubTator, text mining | PubMed |
| Motor end-plate analysis to diagnose immune-mediated myasthenia gravis in seronegative patients. | J Neurol Sci | 2022 | 36403297 | PubTator, text mining | PubMed |
| Engineering Cell Therapies for Autoimmune Diseases: From Preclinical to Clinical Proof of Concept. | Immune Netw | 2022 | 36381961 | PubTator, text mining | PubMed |
| Rapid genome sequencing identifies a novel de novo SNAP25 variant for neonatal congenital myasthenic syndrome. | Cold Spring Harb Mol Case Stud | 2022 | 36379720 | PubTator, text mining | PubMed |
| Kennedy's disease presented with mastication fatigue combined with positive titin antibody: a case report. | BMC Neurol | 2022 | 36376797 | PubTator, text mining | PubMed |
| An odorant receptor that senses four classes of musk compounds. | Curr Biol | 2022 | 36370695 | PubTator, text mining | PubMed |
| New Targeted Agents in Myasthenia Gravis and Future Therapeutic Strategies. | J Clin Med | 2022 | 36362622 | PubTator, text mining | PubMed |
| Proteoglycans Determine the Dynamic Landscape of EMT and Cancer Cell Stemness. | Cancers (Basel) | 2022 | 36358747 | PubTator, text mining | PubMed |
| Metalloproteinases and Tissue Inhibitors in Generalized Myasthenia Gravis. A Preliminary Study. | Brain Sci | 2022 | 36358365 | PubTator, text mining | PubMed |
| Juvenile Myasthenia Gravis in a 14-year-old adolescent masked by mood disorder: the complex balance between neurology and psychiatry. | Acta Myol | 2022 | 36349182 | PubTator, text mining | PubMed |
| A link between agrin signalling and Cav3.2 at the neuromuscular junction in spinal muscular atrophy. | Sci Rep | 2022 | 36347955 | PubTator, text mining | PubMed |
| A late diagnosis of myasthenia gravis at the respiratory practice: back to basics. | Breathe (Sheff) | 2022 | 36337129 | PubTator, text mining | PubMed |
| Sorting nexin 17 increases low-density lipoprotein receptor-related protein 4 membrane expression: A novel mechanism of acetylcholine receptor aggregation in myasthenia gravis. | Front Immunol | 2022 | 36311763 | PubTator, text mining | PubMed |
| Reemergence of pathogenic, autoantibody-producing B cell clones in myasthenia gravis following B cell depletion therapy. | Acta Neuropathol Commun | 2022 | 36307868 | PubTator, text mining | PubMed |
| COVID-19 and myasthenia gravis: A review of neurological implications of the SARS-COV-2. | Brain Behav | 2022 | 36306401 | PubTator, text mining | PubMed |
| Application of lymphoplasmapheresis in the treatment of severe myasthenia gravis. | Front Neurol | 2022 | 36303555 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4593/papers?page=36